Case Series: IV Pentamidine and Keratoplasty with Adjunctive Cryotherapy in the Treatment of Polytherapy- Resistant Acanthamoeba Keratitis
This retrospective case series reports the successful treatment of two polytherapy-resistant Acanthamoeba keratitis cases using a combination of intravenous pentamidine followed by penetrating keratoplasty with adjunctive cryotherapy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human eye is a delicate organ, protected by a clear window called the cornea. Usually, this window stays clean, but sometimes microscopic invaders can slip past our natural defenses. Among the most difficult of these invaders is a tiny, single-celled organism known as Acanthamoeba. This parasite lives in water, soil, and dust, and it can find its way into the eye, often through contact lenses that have not been properly cleaned. Once inside, it burrows into the cornea, causing severe pain, light sensitivity, and a slow, destructive inflammation that can blur vision or even destroy the eye entirely. The challenge for doctors is that this infection is a master of disguise; it often looks like a common bacterial or fungal infection, leading to treatments that fail because they target the wrong enemy. When standard medicines do not work, the infection can become a relentless, sight-threatening crisis that demands more aggressive solutions.
In a recent report, researchers from Stony Brook University and the University of Michigan shared the stories of two women who faced this exact nightmare. Both patients had worn soft contact lenses, and both developed painful, worsening sores on their corneas that did not respond to the usual array of eye drops. They had tried nearly every standard medication available, including various antiseptic solutions and antibiotics, yet the infection continued to spread, forming ring-shaped patterns of damage that signaled a deep, stubborn invasion. The doctors realized that the parasite had become resistant to the many drugs they had tried, a situation where the infection simply refuses to die despite a heavy bombardment of treatment.
Faced with a failing cornea and a patient in severe pain, the medical teams decided to try a different path. They turned to a medication usually given through a vein in the arm, known as intravenous pentamidine. This drug is not typically the first choice for eye infections, but it has the power to reach deep into the body's tissues. The patients received this medicine daily for two weeks, a course designed to attack the parasite from the inside out. However, the doctors knew that simply giving the drug might not be enough to clear the infection completely before surgery. To ensure the parasite was gone, they combined the medication with a surgical procedure called a corneal transplant, where the damaged tissue is removed and replaced with healthy donor tissue. Crucially, during this surgery, they applied a freezing technique to the edge of the remaining eye tissue. This freezing, known as cryotherapy, acts like a targeted frost, killing any lingering microscopic cysts that might have survived the medication or the cutting of the scalpel.
The results of this combined approach were striking. In the first case, a 24-year-old woman who had suffered for months and even undergone an initial, less invasive surgery that failed, received the intravenous drug and the full transplant with freezing. Her pain subsided, the infection did not return, and her vision eventually returned to normal after a follow-up cataract surgery. The second patient, a 60-year-old woman who had been in severe pain for weeks, received the same treatment plan. After the transplant and freezing, the tissue removed from her eye confirmed the presence of the parasite, but the new eye remained clear of infection. She too recovered, with her vision stabilizing as she healed.
This report does not claim that this method is the perfect solution for every case, nor does it suggest that the intravenous drug is without risks, as it can cause side effects like nausea or low blood sugar. Instead, it offers a vital lesson for doctors: when a stubborn eye infection refuses to yield to standard treatments, there are still tools available. By combining a systemic drug delivered through the vein with a surgical transplant that includes a freezing step to clear the edges, it is possible to stop a resistant infection that seemed unstoppable. The story of these two women shows that even when the infection has advanced to a dangerous stage, a determined combination of medicine and surgery can still save the eye and restore sight.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.